The coronavirus (COVID-19) has crippled most of the world by killing not just five-digits worth of lives but also affecting the livelihood and economic sectors as well. The world is still searching for a cure, while the race to create a vaccine has been getting stronger!
Moderna came public with a cancer treatment method that might just be applied to the COVDI-19 vaccine! For now, the estimate on the vaccine's release would be about a year to 18 months later, but with the way current things are going, The Street reports that they may be able to release this vaccine to a limited group (most likely consisting of healthcare workers) as early as this fall!
How does Moderna plan to defeat the COVID-19?
The company is looking at possibly doing their research with an emergency use authorization given by the Food and Drug Administration to help them enter the next stage. Moderna's solution was developed with the partnership of the National Institute of Allergy and Infectious Diseases and is still the fastest potential coronavirus vaccine ever to enter the human trial phase.
Read Also: Piers Morgan Rants During a Debate with Matt Hancock on Good Morning Britain; Frontliners Safety at Risk Amid Coronavirus Pandemic!
The company has taken a very different stance at looking for a cure by making use of messenger RNA instead of relying on the small or inactive samples of the COVID-19 virus itself! Instead of countering the virus specifically by a viral introduction to the subjects who receive it, Moderna has been trying to develop a way for the body to artificially manufacture the similar traits of the coronavirus and slowly build a resistance.
Instead of risking the infection of their subjects, Moderna's solution operates by convincing the body to generate the coronavirus virus resembling proteins that are harmless, but then provoke the necessary antibodies that can fight off the proteins as well as the actual virus itself!
RNA-based treatments
Moderna's approach towards the building of the coronavirus vaccine includes RNA-based vaccine developments. Other types of immune treatments by Moderna have only reached the clinical trial phase so far.
The Boston-based company first came public with the announcement that they are working on mRNA-based treatments for cancer cells way back in December 2018 that was already a huge contribution during that time.
Moderna's procedure in countering the coronavirus.
The vaccine developed by Moderna relies on messenger RNA, making it safer for humans. Since the mRNA testing method does not include the virus, the risk of contracting the virus from the vaccine is eliminated.
This is one of the biggest roadblocks when it comes to virus-based immunity therapy because of the need to expose the subject to the virus for it to build a resistance, which is not always a guaranteed success. With Moderna's methodology, it is not only safer, but it also more humane.
Moderna has finally begun providing the vaccine to volunteer participants that are parts of the first state of human trial. The administration of these vaccines was on Monday, Mar. 23, in Washington State.
Despite the current speed of the testing, the vaccine could only be commercially available after at least a year.
